Dominykas Milašius

Dominykas Milašius is a co-founder of Delta Biosciences, an innovative company focused on developing pharmaceuticals resilient to space conditions. He is actively involved in a groundbreaking mission to test the stability of anti-radiation molecules aboard the International Space Station, which aims to enhance astronaut safety during long-duration space missions. Milašius emphasizes the importance of creating medical solutions specifically for the unique challenges posed by the space environment.